The Future of Vaccines: How to Harness the Full Potential of IVT-RNA

How the market is growing globally, the diseases that IVT-RNA vaccines can protect against, how the market is growing, and the indicators of future growth.

22

January

  • 3PM GMT
  • Free

Why attend?

Speakers

Select a speaker to learn more

Back
Dr. Leslie Friedmann
Product Manager Parallel Capillary Electrophoresis (CE) instruments, Waldbronn
Next speaker
Back
Nancy Jaser, PharmD/MBA
Senior Analyst , GlobalData
Next speaker
Back
Professor Harris Makatsoris
Professor Of Manufacturing Systems in the Department of Engineering at King’s College

Harris is Professor Of Manufacturing Systems in the Department of Engineering at King’s College London. He has a process engineering background with 20-years work experience in both industry and academia. In all his past and present roles, he is managing interdisciplinary projects that require integration and coordination. Harris is an expert in continuous RNA manufacturing. His work is focusing on addressing the challenges in the rapid design, development and scalable manufacture of RNA and other nucleic acids and has pioneered the application of flow technologies in RNA manufacture, of various types. His research has attracted over £25m and he is currently leading a unique multi-disciplinary, multi-million pound programme comprising both industry and academia, building the Biofoundry-in-a-Box (BiaB). The BiaB is a unique portable, multi purpose RNA microfactory designed for the rapid design and deployment of a range of therapeutics and vaccines, with Low and Middle Income Countries in mind. He has several patents in his name in the space of RNA manufacture and continuous bioprocessing and is highly experienced in technology transfer to industry through a variety of commercial routes.

Next speaker

Enquiry